Xuelin Zong

Epithelial–mesenchymal transition in immune escape and immunotherapy resistance of lung cancer

Abstract Epithelial–mesenchymal transition (EMT) drives immunotherapy resistance in lung cancer through three interconnected axes: antigen/checkpoint dysregulation, chemokine remodeling, and metabolic reprogramming. We highlight partial EMT (pEMT) as a clinically prevalent hybrid...